Nomakhosi Mpofana | Biomedical Sciences | Best Researcher Award

Posted on by The Scientist

Best Researcher Award

Nomakhosi Mpofana
Durban University of Technology, South Africa

Nomakhosi Mpofana
Affiliation Durban University of Technology
Country South Africa
Scopus ID 57404183000
Documents 25
Citations 133
h-index 8
Subject Area Biomedical Sciences
Event The Scientist Global Awards
ORCID 0000-0002-3007-1147

Nomakhosi Mpofana is a biomedical sciences researcher affiliated with Durban University of Technology, South Africa. Her scholarly activities contribute to the advancement of biomedical research through investigations that support scientific understanding, evidence-based practice, and health-related innovation. Her publication record, citation performance, and international research visibility demonstrate sustained academic engagement within the biomedical sciences community.[1][2]

Abstract

Nomakhosi Mpofana has established a research profile within biomedical sciences through scholarly publications, collaborative investigations, and contributions to evidence-based scientific knowledge. Her academic work reflects engagement with contemporary biomedical challenges, emphasizing research quality, scientific rigor, and practical relevance. With publications indexed in major scholarly databases and measurable citation impact, her research demonstrates visibility within the international scientific community. The combination of publication productivity, citation performance, and institutional affiliation supports recognition of her contributions to biomedical sciences. These achievements align with the objectives of academic distinction and research excellence recognized through international scientific award programs.[1][2]

Keywords

Biomedical Sciences, Health Research, Clinical Research, Scientific Innovation, Public Health, Medical Science, Research Excellence, Evidence-Based Medicine, Biomedical Innovation, Academic Impact

Introduction

Biomedical sciences play a critical role in advancing healthcare knowledge and improving scientific understanding of human health. Nomakhosi Mpofana contributes to this field through scholarly research activities that support evidence generation and scientific development. Her academic record reflects sustained engagement with biomedical investigations and peer-reviewed publication dissemination.[1]

Research Profile

Affiliated with Durban University of Technology, Nomakhosi Mpofana has developed a recognized research presence in biomedical sciences. Her scholarly portfolio includes publications indexed in Scopus and other academic platforms, demonstrating participation in internationally visible research activities and collaboration within the broader scientific community.[1][2]

Research Contributions

Her research contributions support the advancement of biomedical knowledge through scientific investigations, publication of findings, and participation in research initiatives addressing health-related topics. These contributions enhance understanding within the biomedical sciences field and provide a foundation for future scientific inquiry and application.[1]

Publications

The researcher has produced approximately twenty-five indexed publications, reflecting consistent scholarly productivity. Her work has been disseminated through peer-reviewed academic channels and contributes to the growing body of biomedical literature. Publication activity serves as an indicator of active engagement in scientific research and knowledge dissemination.[4]

Research Impact

Citation metrics indicate that her research has received recognition within the scientific community. With more than one hundred citations and an established h-index, her scholarly output demonstrates academic visibility and influence. These indicators reflect the relevance and utilization of her published work by fellow researchers.[1]

Award Suitability

Nomakhosi Mpofana’s publication record, citation performance, and sustained research engagement align with the objectives commonly associated with research excellence awards. Her measurable academic achievements and contributions to biomedical sciences provide a strong basis for consideration within international scientific recognition programs.[1][2]

Conclusion

The academic profile of Nomakhosi Mpofana reflects meaningful contributions to biomedical sciences through research productivity, scholarly dissemination, and citation impact. Her work demonstrates continued commitment to scientific advancement and supports recognition through professional and international research award initiatives.[1][3]

References

  1. Elsevier. (n.d.). Scopus author details: Nomakhosi Mpofana, Author ID 57404183000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57404183000
  2. ORCID. (n.d.). Nomakhosi Mpofana: ORCID record 0000-0002-3007-1147.https://orcid.org/0000-0002-3007-1147
  3. Google Scholar. (n.d.). Scholar profile of Nomakhosi Mpofana.https://scholar.google.com/citations?user=aVu8JwsAAAAJ&hl=en
  4. ResearchGate. (n.d.). Nomakhosi Mpofana research profile and publication record.https://www.researchgate.net/profile/Nomakhosi-Mpofana

Sukran Ozturk | Pharmaceutical Sciences | Women Researcher Award

Posted on by The Scientist

Assoc. Prof. Dr. Sukran Ozturk | Pharmaceutical Sciences | Women Researcher Award

Faculty of Pharmacy | Zonguldak Bulent Ecevit University | Turkey

Assoc. Prof. Dr. Şükran Öztürk is an Assistant Professor specializing in microbiology, with a strong research focus on antimicrobial resistance, antifungal and antibacterial agents, natural bioactive compounds, and in vivo infection models, particularly Galleria mellonella. She has authored 30+ peer-reviewed publications, accumulating 150 citations, with an h-index of 7 and i10-index of 6. Her work has appeared in reputable international journals such as Molecules, Microbial Pathogenesis, Archives of Microbiology, and Future Microbiology. She has led and collaborated on multidisciplinary studies exploring essential oils, peptides, phage therapy, and synergistic antimicrobial strategies against multidrug-resistant pathogens. Her research contributes to global efforts in combating antimicrobial resistance and advancing alternative therapeutic approaches with potential clinical and societal impact.

Citation Metrics (Google Scholar)

150
100
50
0

Citations

150

h-index

7

i10-index

6

Citations

h-index

i10-index

View Google Scholar Profile
 View Scopus Profile

Featured Publications

Yanan Yang | Pharmaceutical Sciences | Research Excellence Award

Posted on by The Scientist

Ms. Yanan Yang | Pharmaceutical Sciences | Research Excellence Award

Student | Tianjin University of Traditional Chinese Medicine | China

Dr. Yanan Yang is a researcher at Tianjin University of Traditional Chinese Medicine, recognized for her contributions at the intersection of gut microbiota, metabolic regulation, and cardiometabolic diseases. Her scholarly influence is demonstrated by 726 citations, 45 peer-reviewed publications, and an h-index of 14, underscoring her growing impact in biomedical and translational health research. Dr. Yang’s work spans gut microbiome dynamics, microbial metabolites, metabolic disorders, traditional Chinese medicine mechanisms, and multi-omics integration. She has contributed to high-visibility studies on acute coronary syndrome, cardiovascular disease mechanisms, type 2 diabetes regulation, and herbal-medicine-induced metabolic modulation. Her involvement in multi-center collaborations—including meta-analyses with large participant cohorts—reflects her ability to bridge clinical findings with microbiome-mediated insights. Dr. Yang’s publications highlight a consistent focus on understanding microbial signatures, therapeutic pathways, and host–microbe interactions to advance preventive and precision medicine. She has also engaged in studies evaluating herbal interventions such as Coptis chinensis, showcasing the integration of traditional medicine with modern biomedical evidence. With over 223 co-authors across her publication record, her collaborative networks extend nationally and internationally, supporting multidisciplinary innovation in gut–heart metabolic axis research. Dr. Yang’s ongoing contributions provide essential foundations for developing microbiome-based diagnostics, therapeutic strategies for metabolic diseases, and evidence-based applications of traditional Chinese medicine, reflecting her role as an emerging and influential scientist in her field.

Featured Publications

  1. Wu, C., Zhao, Y., Zhang, Y., Yang, Y., Su, W., Yang, Y., Sun, L., Zhang, F., Yu, J., … (2022). Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates prediction of BBR’s cholesterol-lowering efficacy in patients. Journal of Advanced Research, 37, 197–208. Cited by: 78

  2. Dong, C., Yang, Y., Wang, Y., Hu, X., Wang, Q., Gao, F., Sun, S., Liu, Q., Li, L., Liu, J., … (2023). Gut microbiota combined with metabolites reveals unique features of acute myocardial infarction compared with stable coronary artery disease. Journal of Advanced Research, 46, 101–112. Cited by: 74

  3. Dong, C., Yu, J., Yang, Y., Zhang, F., Su, W., Fan, Q., Wu, C., & Wu, S. (2021). Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion. Biomedicine & Pharmacotherapy, 139, 111595. Cited by: 74

  4. Yang, Y. N., Wang, Q. C., Xu, W., Yu, J., Zhang, H., & Wu, C. (2022). The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet-induced hyperlipidemia and stimulates liver LDLR expression. Biomedicine & Pharmacotherapy, 155, 113749. Cited by: 60

  5. Xu, W., Yu, J., Yang, Y., Li, Z., Zhang, Y., Zhang, F., Wang, Q., Xie, Y., Zhao, B., & Wu, C. (2023). Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic. Gut Microbes, 15(1), 2228045. Cited by: 57

Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Posted on by The Scientist

Prof. Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Prof in General Practice | University of Tasmania | Australia

Professor Jan Radford is a distinguished academic in general practice and medical education, currently based at the Tasmanian School of Medicine, University of Tasmania. With over three decades of professional and academic experience, she has contributed extensively to curriculum design, health professional education, and research capacity building within primary care. She has authored 59 peer-reviewed publications, which have collectively received over 535 citations, reflecting her sustained influence in the field. Professor Radford’s scholarly and leadership contributions span undergraduate, postgraduate, and vocational levels of medical education. As a long-serving faculty member, she has played a pivotal role in shaping the University of Tasmania’s medical curriculum, particularly through initiatives such as the development of innovative rural and aged care placements. Her leadership as Director of the Launceston Clinical School (2022–2024) further strengthened community-based clinical education and interprofessional collaboration across Tasmania. Nationally, she has held major roles in the Royal Australian College of General Practitioners (RACGP), notably serving as Censor-in-Chief, where she oversaw educational quality assurance, specialty recognition, and the advancement of Indigenous health education. Her work in developing the GP MAGIC framework and establishing Tasmania’s practice-based research network has fostered practitioner-led inquiry and evidence-informed primary care. A 2017 Churchill Fellow, Professor Radford investigated the use of routinely collected general practice electronic health data to enhance patient outcomes. This aligns with her ongoing research focus on integrating e-health data, clinical audit, and educational innovation to improve general practice systems and learning environments. Through her extensive collaborations and commitment to translating research into practice, Professor Radford continues to influence healthcare education and delivery in Australia and beyond, contributing meaningfully to the advancement of community-oriented, data-informed primary care.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., Brett, T., Radford, J., et al. (2021). Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia. Heart, Lung and Circulation, 30(3), 324–349. https://doi.org/10.1016/j.hlc.2020.10.013 — 108 citations

  2. Fan, S., Radford, J., & Fabian, D. (2016). A mixed-method research to investigate the adoption of mobile devices and Web 2.0 technologies among medical students and educators. BMC Medical Informatics and Decision Making, 16(1), 43. https://doi.org/10.1186/s12911-016-0282-4 — 52 citations

  3. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., Salahudeen, M. S., et al. (2022). Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: A population-based cohort study. Journal of the American Heart Association, 11(7), e023098. https://doi.org/10.1161/JAHA.121.023098 — 46 citations

  4. Castelino, R. L., Saunder, T., Kitsos, A., Peterson, G. M., Jose, M., Wimmer, B., Radford, J., et al. (2020). Quality use of medicines in patients with chronic kidney disease. BMC Nephrology, 21(1), 216. https://doi.org/10.1186/s12882-020-01849-7 — 37 citations

  5. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., & Curtain, C. (2021). Ten-year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation. Frontiers in Pharmacology, 12, 586370. https://doi.org/10.3389/fphar.2021.586370 — 36 citations

Latifah Al Shammari | Pharmaceutical Sciences | Best Researcher Award

Posted on by The Scientist

Dr. Latifah Al Shammari | Pharmaceutical Sciences | Best Researcher Award

Assistant professor at University of Hafr Albatin, Saudi Arabia 

Dr. Latifah Al Shammari is an accomplished Assistant Professor at the University of Hafr Al Batin, specializing in Pharmacognosy and Nutraceuticals . She holds degrees from King Saud University and a Ph.D. from Charles University, Czech Republic . With extensive experience as a Consultant Pharmacist , she has served in leadership roles, including Supervisor of Pharmacy Services at the Ministry of Health’s King Khalid General Hospital . Dr. Latifah is passionate about medication safety, academic excellence, and community health promotion, having actively participated in numerous conferences and World Health Day events . Her research, spanning over a dozen publications in indexed journals , focuses on advancing natural product sciences and nutraceutical innovations. Recognized with multiple awards , including a Research Excellence Award from the Second Riyadh Health Cluster, she continues to inspire through her scholarship, dedication, and contributions to Saudi Arabia’s growing pharmaceutical research landscape.

Professional Profile

Google Scholar

Education 

Dr. Latifah Al Shammari began her academic journey with a Bachelor’s degree in Pharmaceutical Sciences (Pharmacognosy)  from King Saud University, Riyadh . Her passion for natural product chemistry and therapeutic applications led her to pursue a Master’s degree in the same specialization , where she honed her skills in bioactive compound isolation and pharmacological evaluation. Striving for global academic exposure, she earned her Ph.D. in Pharmacognosy and Nutraceuticals  from Charles University, Prague , a prestigious institution known for its rigorous scientific research. Throughout her education, she engaged in interdisciplinary studies combining botany , chemistry , and pharmacology, equipping her with the expertise to bridge traditional knowledge with modern therapeutic science. Her academic journey reflects a balance of strong foundational training and advanced research skills, enabling her to contribute meaningfully to the field of medicinal plant research, nutraceutical development, and pharmaceutical education, both locally and internationally .

Experience 

Dr.  Latifah Al Shammari career spans academia, healthcare leadership, and community health advocacy. She currently serves as an Assistant Professor at the University of Hafr Al Batin , where she teaches, mentors, and conducts research in Pharmacognosy and Nutraceuticals . Previously, she was a Consultant Pharmacist and Supervisor of Pharmacy Services at the Ministry of Health’s King Khalid General Hospital , overseeing medication safety and quality assurance. She has also worked as a Medication Safety Officer  and media representative for the Pharmaceutical Care Department, promoting rational drug use and patient safety . Her dedication extends to public health education through participation in World Health Day initiatives  and awareness campaigns. Over the years, she has built research collaborations, attended national and international conferences, and contributed significantly to pharmaceutical education and policy development. Her multidisciplinary experience blends research expertise with practical healthcare solutions, impacting both the academic and clinical sectors .

Research Interest

Dr. Latifah Al Shammari research is anchored in Pharmacognosy and Nutraceuticals , exploring bioactive compounds from natural sources and their therapeutic applications. She is deeply interested in isolating and characterizing plant-derived molecules , evaluating their pharmacological potential against chronic diseases, and developing nutraceutical formulations for preventive healthcare. Her studies integrate traditional medicinal knowledge with modern analytical techniques , aiming to create safe, effective, and sustainable alternatives to synthetic drugs. Additionally, she is passionate about medication safety , optimizing therapeutic outcomes while minimizing adverse effects. She actively explores functional foods, herbal pharmacology, and the role of natural compounds in immune modulation and antioxidant defense. Collaborating with multidisciplinary teams , she seeks to bridge the gap between traditional medicine and evidence-based clinical practice. Her research not only addresses scientific innovation but also contributes to global health goals , sustainability, and the advancement of Saudi Arabia’s pharmaceutical research ecosystem .

Award and Honor

Dr. Latifah Al Shammari dedication to research and community service has earned her multiple accolades. She received the Research Award from the Second Riyadh Health Cluster  for her outstanding contributions to pharmaceutical sciences. Her excellence has been recognized with certificates of appreciation from King Saud University  and the Ministry of Health , highlighting her commitment to education, clinical service, and patient safety. She has been honored at both local and international conferences  for her impactful presentations and research findings in Pharmacognosy and Nutraceuticals . In addition, she has been acknowledged for her efforts in public health education , particularly during World Health Day events. These recognitions reflect her dual commitment to advancing scientific knowledge and promoting community well-being. Through her achievements, Dr. Latifah stands out as a role model for aspiring scientists, blending academic excellence with societal impact .

Research Skill

Dr. Latifah Al Shammari possesses a robust skill set in natural products research , including phytochemical extraction, isolation, and structural characterization using advanced analytical techniques such as chromatography and spectroscopy . She is proficient in designing and executing pharmacological assays to evaluate bioactivity, particularly antioxidant, antimicrobial, and anti-inflammatory properties . Her expertise extends to nutraceutical formulation , safety assessment, and quality control. She demonstrates strong scientific writing  and has published multiple peer-reviewed articles in indexed journals . Additionally, she excels in literature review, data interpretation , and research project management. Her collaborative mindset has facilitated interdisciplinary partnerships, enhancing research impact and innovation. She is also experienced in academic teaching, mentoring graduate students , and presenting at international conferences . Combining technical precision with creative problem-solving, Dr. Latifah continues to contribute to advancing pharmacognosy, nutraceutical development, and evidence-based herbal medicine .

Publication Top Notes

Title: Chemical composition and antimicrobial activity of the essential oil and lipid content of Carduus pycnocephalus L. growing in Saudi Arabia
Authors: L.A. Al-Shammari, W.H.B. Hassan, H.M. Al-Youssef
Journal: Journal of Chemical and Pharmaceutical Research, 4 (2), 1281-1287
Year: 2012
Cited by: 33

Title: Amaryllidaceae alkaloids from Hippeastrum x hybridum cv. Ferrari, and preparation of vittatine derivatives as potential ligands for Alzheimer’s disease
Authors: L. Al Shammari, D. Hulcová, J. Maříková, T. Kučera, M. Šafratová, …
Journal: South African Journal of Botany, 136, 137-146
Year: 2021
Cited by: 26

Title: Alkaloid profiling of Hippeastrum cultivars by GC-MS, isolation of Amaryllidaceae alkaloids and evaluation of their cytotoxicity
Authors: L. Al Shammari, A. Al Mamun, D. Koutová, M. Majorošová, D. Hulcová, …
Journal: Records of Natural Products, 14 (2), 154-159
Year: 2020
Cited by: 26

Title: Phytochemical and biological studies of Carduus pycnocephalus L.
Authors: L.A. Al-Shammari, W.H.B. Hassan, H.M. Al-Youssef
Journal: Journal of Saudi Chemical Society, 19 (4), 410-416
Year: 2015
Cited by: 26

Title: Structure elucidation and cholinesterase inhibition activity of two new minor Amaryllidaceae alkaloids
Authors: J. Maříková, A.A. Mamun, L.A. Shammari, J. Korábečný, T. Kučera, D. Hulcová, …
Journal: Molecules, 26 (5), 1279
Year: 2021
Cited by: 23

Title: New pentacyclic triterpene ester and flavone glycoside from the biologically active extract of Carduus pycnocephalus L.
Authors: W.H.B. Hassan, H.M. Al-Youssef, A.L.S. Latifa, R.H. Abdallah
Journal: Journal of Pharmacognosy and Phytotherapy, 7 (4), 45-55
Year: 2015
Cited by: 9

Title: Derivatives of montanine-type alkaloids and their implication for the treatment of Alzheimer’s disease: Synthesis, biological activity and in silico study
Authors: N. Maafi, F. Pidaný, J. Maříková, J. Korábečný, D. Hulcová, T. Kučera, …
Journal: Bioorganic & Medicinal Chemistry Letters, 51, 128374
Year: 2021
Cited by: 6

Title: Amaryllidaceae alkaloids from Hippeastrum x hybridum cv. Ferrari, and preparation of vittatine derivatives as potential ligands for Alzheimer’s disease
Authors: L.A. Shammari, D. Hulcová, J. Marikova, T. Kucera, M. Safratova, L. Nováková, …
Journal: South African Journal of Botany, 1-10
Year: 2020
Cited by: 5

Title: Alkaloids of genus Hippeastrum (Amaryllidaceae): isolation, identification, biological activity
Authors: L.A.M. Al Shammari
Journal: Univerzita Karlova, Farmaceutická fakulta v Hradci Králové
Year: 2021
Cited by: 1

Conclusion

Dr. Latifah Al Shammari and collaborators demonstrates a sustained and impactful contribution to natural product chemistry, phytochemistry, and bioactive compound discovery. Spanning over a decade, these studies have advanced understanding of essential oils, alkaloids, and plant-derived metabolites with significant antimicrobial, cytotoxic, neuroprotective, and therapeutic potential. The research not only enriches botanical and pharmacological knowledge but also provides promising leads for drug discovery in areas such as Alzheimer’s disease, cancer, and infectious diseases, highlighting the author’s role as a prominent and innovative contributor to pharmaceutical sciences.